- Home
- SCLX vs STG Comparison
SCLX vs STG Comparison
Compare SCLX & STG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- STG
- Stock Information
- Founded
- SCLX 2011
- STG 2003
- Country
- SCLX United States
- STG China
- Employees
- SCLX N/A
- STG N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- STG Other Consumer Services
- Sector
- SCLX Health Care
- STG Real Estate
- Exchange
- SCLX Nasdaq
- STG Nasdaq
- Market Cap
- SCLX 81.7M
- STG 83.8M
- IPO Year
- SCLX N/A
- STG 2018
- Fundamental
- Price
- SCLX $0.48
- STG $6.45
- Analyst Decision
- SCLX Strong Buy
- STG
- Analyst Count
- SCLX 3
- STG 0
- Target Price
- SCLX $11.33
- STG N/A
- AVG Volume (30 Days)
- SCLX 184.3K
- STG 4.7K
- Earning Date
- SCLX 12-24-2024
- STG 11-22-2024
- Dividend Yield
- SCLX N/A
- STG N/A
- EPS Growth
- SCLX N/A
- STG N/A
- EPS
- SCLX N/A
- STG 4.57
- Revenue
- SCLX $50,833,000.00
- STG $292,030,936.00
- Revenue This Year
- SCLX $32.77
- STG N/A
- Revenue Next Year
- SCLX $50.71
- STG N/A
- P/E Ratio
- SCLX N/A
- STG $1.46
- Revenue Growth
- SCLX 9.41
- STG N/A
- 52 Week Low
- SCLX $0.46
- STG $4.25
- 52 Week High
- SCLX $2.63
- STG $12.55
- Technical
- Relative Strength Index (RSI)
- SCLX 33.34
- STG 49.04
- Support Level
- SCLX $0.48
- STG $6.10
- Resistance Level
- SCLX $0.54
- STG $6.68
- Average True Range (ATR)
- SCLX 0.06
- STG 0.30
- MACD
- SCLX -0.00
- STG 0.04
- Stochastic Oscillator
- SCLX 4.53
- STG 63.95
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.